Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma
NCT02977702 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 114
Last updated 2016-11-30
Summary
The primary objective of this study was to validate Total Psoas Area (TPA) measurement as an independent prognostic factor of overall survival in patients with pancreatic adenocarcinoma. Secondary objective was to describe the evolution of the TPA during the follow-up.
Conditions
- Pancreatic Neoplasms
Sponsors & Collaborators
-
Institut de Cancérologie de Lorraine
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-31
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
More Related Trials
-
Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable
NCT02818907 ·Status: COMPLETED ·Phase: NA
-
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
NCT05287347 ·Status: WITHDRAWN
-
SARcopenia in Patients With ChrOnic PANcreatitis: the SARCOPAN Study
NCT06092307 ·Status: UNKNOWN ·Phase: NA
-
Risk Factors of Postoperative Complications and Survival Rate in Pancreatic Ductal Adenocarcinoma Patients
NCT06378853 ·Status: COMPLETED
-
Patient Reported Outcomes Registry in Patient With Cancer Cachexia
NCT02983500 ·Status: COMPLETED
-
The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma
NCT06553040 ·Status: COMPLETED
-
Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma
NCT02974764 ·Status: COMPLETED
-
Lipoprotein a is an Independent Risk Factor for Overall Survival in Patients With Pancreatic Cancer: a Propensity Score Matching Analysis
NCT06316466 ·Status: RECRUITING
-
Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas
NCT06311032 ·Status: COMPLETED
-
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic Risk
NCT02478892 ·Status: RECRUITING
-
Management of Symptomatic Advanced Pancreatic Adenocarcinoma
NCT02979483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prognostic and Predictive Markers of Treatment Response in Patients With PAC.
NCT05776342 ·Status: RECRUITING
-
PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.
NCT06815172 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of an Adapted Physical Activity Program in Patients With Unresectable Pancreatic Cancer
NCT02184663 ·Status: UNKNOWN ·Phase: NA
-
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05642962 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
NCT06122896 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT00912717 ·Status: RECRUITING
-
Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis
NCT03524677 ·Status: UNKNOWN
-
A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma
NCT05547074 ·Status: COMPLETED
-
Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI
NCT05511116 ·Status: UNKNOWN
-
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer
NCT05692323 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
NCT06151223 ·Status: RECRUITING
-
Early Screening of Pancreatic Lesions : Development of New Imaging Tools
NCT04007640 ·Status: UNKNOWN ·Phase: NA
-
Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma
NCT06705335 ·Status: RECRUITING
-
Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions
NCT03486327 ·Status: TERMINATED ·Phase: PHASE2